Short answer
NATIONAL HEALTH INVESTORS INC (NHI) filed its Q2 2026 10-Q quarterly report on Aug 10, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $45M (up 215.0% year over year) with net income of $56M.
Q2 2026 key financials · XBRL
- Revenue
- $45M
- +215.0% YoY · +20.8% QoQ
- Net income
- $56M
- +50.5% YoY · +38.8% QoQ
- EPS (diluted)
- $1.15
- +45.6% YoY · +40.2% QoQ
Source: XBRL data from the NATIONAL HEALTH INVESTORS INC (NHI) Q2 2026 10-Q on SEC EDGAR. USD.
NATIONAL HEALTH INVESTORS INC Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Six-month NOI $168.977M vs $152.908M YoY, up $16.069M
- Best segment Real Estate Investments, NOI $149.064M versus SHOP $19.913M
- NHC portfolio sale completed July 1 for $560.0M cash consideration
- Acquisitions totaled $229.886M; dispositions generated $98.461M net proceeds
- Headwinds: inflation, interest rates, tenant financial difficulties, and reimbursement changes
Risk Factors
- New risk: NHC property-sale proceeds may not generate comparable returns after redeployment
- Redeployment risk: Suitable investments, market conditions, competition, and cost of capital may constrain reinvestment
- Operational risk: Inability to replace sold NHC assets could adversely impact results of operations
- Regulatory and compliance risks: No material changes from the 10-K disclosed
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other NATIONAL HEALTH INVESTORS INC quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.